DBV TECHNOLOGIES
DEAD

Serial Number

79155398

Owner

DBV TECHNOLOGIES

Attorney

James R Menker

Filing Date

Jul 18, 2014

Add to watchlist:

No watchlists yet
View on USPTO

DBV TECHNOLOGIES Trademark

Serial Number: 79155398 • Registration: 4750180

DBV TECHNOLOGIES is a trademark filed by DBV TECHNOLOGIES on July 18, 2014. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

DBV TECHNOLOGIES (42 trademarks)

177-181 avenue Pierre Brossolette
Montrouge 92120 , FR

Entity Type: 99

DBV TECHNOLOGIES (Société Anonyme) (2 trademarks)

177-181 avenue Pierre Brossolette

Entity Type: 99

Trademark Details

Filing Date

July 18, 2014

Registration Date

June 9, 2015

Published for Opposition

March 24, 2015

Cancellation Date

July 19, 2024

Goods & Services

Medicated adhesive devices in the nature of epicutaneous patches for enabling cutaneous or epicutaneous administration of medicated or pharmaceutical substances in powder form for humans and animals for the treatment of allergies, inflammatory and autoimmune diseases; epicutaneous patches featuring a preparation in powder form for medical purposes for the treatment of allergies, inflammatory and autoimmune diseases; medicated occlusion patches in the nature of epicutaneous patches for enabling the absorption of a medicated substance in powder form via the skin for the treatment of allergies, inflammatory and autoimmune diseases

Medical services that use a desensitization method that uses immunotherapy; medical treatments of allergies and inflammatory and autoimmune diseases via administration of allergens, antigens using a patch to be affixed to the unbroken skin of the patient, thus avoiding the allergen being transferred into the blood; medical treatments of allergies and inflammatory and autoimmune diseases that use the epicutaneous method of desensitization via immunotherapy; epicutaneous medical treatments of allergies and inflammatory and autoimmune diseases without prior preparation of the skin other than for simple, light cleansing to keep the cellular structure of the epidermis intact; medical consultancy in the field of desensitization to allergies relating to desensitization to combat allergies

Medical apparatus, instruments and devices, namely, epicutaneous patches for the cutaneous or epicutaneous administration of substances of medicated or cosmetic substances in powder form for humans or animals sold without medication; occlusion patch dispensers for medical purposes; medical instruments using the electrostatic properties of a biocompatible support, namely, epicutaneous patches sold without medication

Medical and scientific research in the field of immunotherapy, namely, designing scientific methods for epicutaneous immunotherapy without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact; scientific research in the field of treating and caring for allergies; scientific research in the field of allergy treatment for a treatment to be applied repeatedly to the skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact and thus avoiding the passage of the allergen into the blood; discovery and development of allergen drugs; medical and scientific research, namely, designing methods for treating allergies via the combination of allergens with immune cells in the skin; medical and scientific research, namely, designing methods for treating allergies via the application of a patch to the unbroken skin of the patient without prior preparation of the skin other than simple and light cleaning in order to leave the cell structure of the skin intact

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Feb 8, 2025 DETH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 13, 2024 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Jun 15, 2024 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 25, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 26, 2022 INTS
INVALIDATION PROCESSED
Sep 26, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 24, 2022 INTR
CANCELLED SECTION 71
Dec 24, 2021 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Nov 1, 2021 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 4, 2017 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 30, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 30, 2015 FICS
FINAL DISPOSITION PROCESSED
Sep 30, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 9, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 9, 2015 R.PR
NOTIFICATION PROCESSED BY IB
Apr 4, 2015 GPNX
PUBLISHED FOR OPPOSITION
Mar 24, 2015 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 18, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 18, 2015 OP2R
NOTICE OF PUBLICATION
Mar 4, 2015 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 19, 2015 PREV
ASSIGNED TO LIE
Feb 13, 2015 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 22, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 21, 2015 TROA
NON-FINAL ACTION MAILED
Jan 13, 2015 CNRT
NON-FINAL ACTION WRITTEN
Jan 12, 2015 CNRT
REFUSAL PROCESSED BY IB
Dec 27, 2014 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 22, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2014 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 9, 2014 RFCS
REFUSAL PROCESSED BY MPU
Dec 9, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 5, 2014 RFCR
APPLICATION FILING RECEIPT MAILED
Dec 5, 2014 MAFR
NON-FINAL ACTION WRITTEN
Dec 4, 2014 CNRT
ASSIGNED TO EXAMINER
Dec 1, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 1, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 27, 2014 REPR